Ignite Creation Date:
2025-12-25 @ 1:17 AM
Ignite Modification Date:
2026-01-05 @ 12:48 AM
Study NCT ID:
NCT05673993
Status:
COMPLETED
Last Update Posted:
2025-10-01
First Post:
2022-12-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Efficacy and Safety of Telitacicept in Subjects With Active Primary Sjogren's Syndrome
Sponsor:
RemeGen Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-04-06
Start Date Type:
ACTUAL
Primary Completion Date:
2024-10-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-05-06
Completion Date Type:
ACTUAL
First Submit Date:
2022-12-29
First Submit QC Date:
None
Study First Post Date:
2023-01-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-30
Last Update Post Date:
2025-10-01
Last Update Post Date Type:
ESTIMATED